Evidence map›Paper›PMID 38915931›Full record

ArticleClinical case reports2024

Trastuzumab-induced toxic epidermal necrolysis in a Her-2-positive metastatic breast cancer patient-A rare case report.

Jannatul Ferdause, Sura Jukrup Momtahena, Rubama Karim, Aditi Paul Chowdhury, Nowshin Taslima Hossain, Md Ariful Islam, Maruf Bin Habib, A K M Shafiul Kadir, Md Ariful Haque

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Complete disappearance of ductal carcinomaAnnals of medicine and surgery (2012) · 2026
    Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jannatul FerdauseAhsania Mission Cancer and General Hospital Dhaka Bangladesh.
Sura Jukrup MomtahenaAhsania Mission Cancer and General Hospital Dhaka Bangladesh.
Rubama KarimAhsania Mission Cancer and General Hospital Dhaka Bangladesh.
Aditi Paul ChowdhuryAhsania Mission Cancer and General Hospital Dhaka Bangladesh.
Nowshin Taslima HossainAhsania Mission Cancer and General Hospital Dhaka Bangladesh.
Md Ariful IslamAhsania Mission Cancer and General Hospital Dhaka Bangladesh.
Maruf Bin HabibDepartment of Medicine Ahsania Mission Medical College Dhaka Bangladesh.
A K M Shafiul KadirQuest Bangladesh Biomedical Research Center Dhaka Bangladesh.
Md Ariful HaqueDepartment of Public Health Atish Dipankar University of Science and Technology Dhaka Bangladesh.ORCID https://orcid.org/0000-0003-4632-5153

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Toxic Epidermal Necrolysis (TEN) is a rare, but potentially fatal mucocutaneous reaction, that may occur due to an immunologic response to certain medications. However, TEN triggered by Trastuzumab is extremely rare. Early diagnosis, recognition, and prompt cessation of the offending drugs and initiation of steroid therapy with supportive management are the most important actions for managing TEN. Although rare, it is important to be vigilant about this potential adverse reactions associated with trastuzumab to ensure patient safety and contribute to better outcomes.

Indexed as

anti HER‐2 antibodyHER‐2‐positive breast cancerSteven Johnson syndrometoxic epidermal necrolysisTrastuzumab

Identifiers

PMID38915931
PMCPMC11194292

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.